DC
IRD

Diametric Capital’s Opus Genetics IRD Stock Holding History

Diametric Capital’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-29,299
Closed -$34.9K – 395
2024
Q4 		$34.9K Sell
29,299
-3,952
-12% -$4.54K 0.02% 291
2024
Q3 		$43.6K Sell
33,251
-4,784
-13% -$7.37K 0.02% 351
2024
Q2 		$58.2K Sell
38,035
-13,359
-26% -$23.1K 0.03% 327
2024
Q1 		$103K Sell
51,394
-21,937
-30% -$55.6K 0.06% 294
2023
Q4 		$221K Buy
73,331
+17,272
+31% +$51.1K 0.13% 190
2023
Q3 		$188K Buy
56,059
+27,846
+99% +$112K 0.08% 281
2023
Q2 		$122K Sell
28,213
-27,435
-49% -$130K 0.05% 274
2023
Q1 		$209K Buy
55,648
+32,050
+136% +$115K 0.1% 230
2022
Q4 		$83.3K Sell
23,598
-950
-4% -$2.5K 0.04% 255
2022
Q3 		$49K Sell
24,548
-9,808
-29% -$21.2K 0.02% 243
2022
Q2 		$66K Sell
34,356
-17,175
-33% -$39K 0.05% 230
2022
Q1 		$166K Sell
51,531
-37,911
-42% -$130K 0.09% 198
2021
Q4 		$334K Buy
+89,442
New +$359K 0.26% 78

Other funds holding IRD

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $179M AUM 37.68% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Diametric Capital's IRD Position: Q1 2025 in Review

Diametric Capital sold out of Opus Genetics (IRD) in Q1 2025, closing a stake of 29,299 shares — an estimated $34.9K sold.

Diametric Capital first reported a position in IRD in Q4 2021 and held it in 13 quarters. The position peaked at $334K in Q4 2021. 46 funds tracked by Wall St. Rank hold IRD as of Q1 2025.

  • Diametric Capital reported no remaining Opus Genetics position as of Q1 2025 after selling out during the quarter.
  • Diametric Capital sold 29,299 Opus Genetics shares in Q1 2025, an estimated $34.9K.
  • Diametric Capital first reported a position in Opus Genetics in Q4 2021 and held it in 13 quarters.
  • Diametric Capital's Opus Genetics position peaked at $334K in Q4 2021.
  • 46 funds tracked by Wall St. Rank held Opus Genetics as of Q1 2025.

Based on Diametric Capital's 13F filing for Q1 2025, filed 14 May 2025.